Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India

Health Policy and Planning

Volumn 28, Issue 1, 2013, Pages 51-61

  Gupta, Madhu ^a   Prinja, Shankar ^a   Kumar, Rajesh ^a   Kaur, Manmeet ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Cost effectiveness; Hib; incremental cost; India; model; vaccine

Indexed keywords

HAEMOPHILUS VACCINE;

ARTICLE; COST BENEFIT ANALYSIS; COST OF ILLNESS; ECONOMICS; HAEMOPHILUS INFECTION; HUMAN; IMMUNIZATION; INCIDENCE; INDIA; QUALITY ADJUSTED LIFE YEAR; STATISTICAL MODEL; TREATMENT OUTCOME; HAEMOPHILUS INFECTIONS;

COST OF ILLNESS; COST-BENEFIT ANALYSIS; HAEMOPHILUS INFECTIONS; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INCIDENCE; INDIA; MODELS, ECONOMIC; QUALITY-ADJUSTED LIFE YEARS; TREATMENT OUTCOME;

EID: 84872241682     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czs025     Document Type: Article

References (58)

1. Acharya D, Prasanna KS, Nair S, Rao RSP. 2003. Acute respiratory infections in children: a community based longitudinal study in south India. Indian Journal of Public Health 47: 7-13.
2. Adams WG, Deaver KA, Cochi SL et al. 1993. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. Journal of American Medical Association 269: 221-6.
3. Adegbola RA, Secka O, Lahai G et al. 2005. Elimination of Haemophilus influenzae type b (Hib) disease from the Gambia after the introduction of routine immunization with a Hib conjugate vaccine: a prospective study. The Lancet 366: 144-50.
4. Akumu AO, English M, Scott JAG, Griffiths UK. 2007. Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya. Bulletin of the World Health Organization 85: 511-18.
5. Alvis Guzmán N, De La Hoz Restrepo F, Vivas Consuelo D. 2006. The cost-effectiveness of Haemophilus influenzae type b vaccine for children under 2 years of age in Colombia. Pan American Journal of Public Health 20: 248-55.
6. Bahl R, Mishra S, Sharma D, Singhal A, Kumari S. 1995. A bacteriological study in hospitalized children with pneumonia. Annals of Tropical Paediatrics 15: 173-7.
7. Booy R, Hodgson S, Carpenter L et al. 1994. Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T. The Lancet 344: 362-6.
8. Byres TJ, Lerche J, Kapadia K. 1999. Rural Labour Relations in India. London: Frank Cass.
9. Chinchankar N, Mane M, Bhave S et al. 2002. Diagnosis and outcome of acute bacterial meningitis in early childhood. Indian Pediatrics 39: 914-21.
10. Darmstadt GL, Bhutta ZA, Cousens S et al. 2005. Evidence-based, costeffective interventions: how many newborn babies can we save? The Lancet 365: 977-88.
11. Datta N, Kumar V, Kumar L, Singhi S. 1987. Application of case management to the control of acute respiratory infections in low birth weight infants: a feasibility study. Bulletin of the World Health Organization 65: 77-82.
12. Disease Control Priorities Project (DCPP). 2006. Costs and costeffectiveness of adding new antigens to the current immunization schedule. Online at: http://www.dcp2.org/pubs/DCP/20/Section/2696, accessed 2 October 2008.
13. Eskola J, Käyhty H, Takala AK et al. 1990. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. New England Journal of Medicine 323: 1381-7.
14. GAVI. 2009. GAVI's impact on vaccine market is bringing down prices. Online at: http://www.gavialliance.org/media-centre/press-releases/2009-11-18- vaccine-market-impact.php, accessed 7 February 2011.
15. Gessner BD, Sutanto A, Linehan M et al. 2005. Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial. The Lancet 365: 43-52.
16. Government of Haryana. 2010a. Economic Survey of Haryana 2009-10. Department of Economic and Statistical Analysis, Haryana. Online at: http://esaharyana.gov.in/Default2.aspx?PName¼Economic%20 Survey%20of%20Haryana, accessed 22 July 2010.
17. Government of Haryana. 2010b. Haryana Budget 2010-11. Online at: http://haryananews.org/haryana-budget-2010-11/archives/3035, accessed 28 June 2010.
18. Gupta M, Kumar R, Deb AK et al. 2010. Multi-center surveillance for pneumonia & meningitis among children
19. Hib Initiative. 2009. Update on cost-effectiveness tool for Hib vaccine. The Hib Initiative News. Online at: http://www.hibaction.org/, accessed 28 June 2010.
20. Hussain H, Waters H, Omer S B et al. 2006. The cost of treatment for child pneumonias and meningitis in the Northern Areas of Pakistan. International Journal of Health Planning and Management 21: 229-38.
21. Indian Council of Medical Research (ICMR). 2008. Estimating the preventable burden of Haemophilus influenza type b, Meningitis and Pneumonia in India. 2008. Part A Report. New Delhi: Indian Council of Medical Research.
22. International Institute of Population Sciences (IIPS). 2007. National Family Health Survey-3. Indian Institute of Population Sciences, Ministry of Health and Family Welfare, New Delhi. Online at: http://www.nfhsindia.org/ factsheet.html, accessed 1 July 2007.
23. Invasive Bacterial Infections Surveillance (IBIS) Group. 1998. Invasive Haemophilus influenzae disease in India: a preliminary report of prospective multihospital surveillance. Pediatric Infectious Disease Journal 17: S172-5.
24. Invasive Bacterial Infections Surveillance (IBIS) Group. 2002. Are Haemophilus influenzae infections a significant problem in India? A prospective study and review. Clinical Infectious Diseases 34: 949-57.
25. Kabra SK, Kumar P, Verma IC et al. 1991. Bacterial meningitis in India: an IJP survey. Indian Journal of Pediatrics 58: 505-11.
26. Kumar L, Ayyagari A. 1984. The etiology of lobar pneumonia and empyema thoracis in children. Indian Pediatrics 21: 133-8.
27. Levine OS, Ortiz E, Contreras R et al. 1993. Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile. American Journal of Epidemiology 137: 1221-8.
28. Levine OS, Schwartz B, Pierce NF, Kane M. 1998. Development, evaluation and implementation of Hib vaccines for young children in developing countries: current status and priority actions. Pediatric Infectious Disease Journal 17: S95-113.
29. Levine OS, Lagos R, Munoz A et al. 1999. Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b. Pediatric Infectious Disease Journal 18: 1060-4.
30. Lewis R, Kisakye A, Gessner B et al. 2008. Action for child survival: elimination of Haemophilus influenzae type b meningitis in Uganda. Bulletin of the World Health Organization 86: 292-301.
31. Madsen HO, Hanehøj M, Das AR et al. 2009. Costing of severe pneumonia in hospitalized infants and children aged 2-36 months, at a secondary and tertiary level hospital of a not-for-profit organization. Tropical Medicine and International Health 14: 1315-22.
32. Miller MA. 1998. An assessment of the value of Haemophilus influenzae type b conjugate vaccine in Asia. Pediatric Infectious Disease Journal 17: S152-9.
33. Million Death Study Collaborators. 2010. Causes of neonatal and child mortality in India: a nationally representative mortality survey. The Lancet 376: 1853-60.
34. Ministry of Health and Family Welfare (MOHFW). 2006. District Level Household & Fertility Survey. Reproductive and Child Health Project. Online at: http://www.rchiips.org/ARCH-1.html, accessed 28 June 2010.
35. Minz S, Balraj V, Lalitha MK et al. 2008. Incidence of Haemophilus influenzae type b meningitis in India. Indian Journal of Medical Research 128: 57-64.
36. Mulholland K, Hilton S, Adegbola R et al. 1997. Randomized trial of Haemophilus influenzae type b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants. The Lancet 349: 1191-7.
37. Murray CJL, Lopez AD. 1996. The Global Burden of Disease. Geneva: World Health Organization, Harvard School of Public Health, World Bank.
38. National Sample Survey Organisation (NSSO). 2006. NSS 61st Round. National Sample Survey Organization, Ministry of Statistics and Programme Implementation, New Delhi. Online at: http://mospi .gov.in/ndb-rpts.htm, accessed 25 March 2010.
39. Patwari AK, Bisht S, Srinivasan A, Deb M, Chattopadhya D. 1996. Aetiology of pneumonia in hospitalized children. Journal of Tropical Pediatrics 42: 15-20.
40. Peltola H. 1999. Spectrum and burden of severe Haemophilus influenzae type b diseases in Asia. Bulletin of the World Health Organization 77: 878-87.
41. Prinja S, Gupta M, Singh AJ, Kumar R. 2010. Effectiveness of decentralized program planning and management in improving age appropriate immunizations in a rural area of India. Bulletin of the World Health Organization 88: 97-103.
42. Registrar General of India. 2001. Final population totals and household amenities: Haryana. Census of India 2001, Registrar General of India. Online at: http://www.censusindia.net/results/catalogue/pdf, accessed 12 April 2008.
43. Registrar General of India. 2006. Population projections for India and states 2001 to 2026. Report of the Technical Group on Population Projections constituted by the National Commission on Population. New Delhi: Registrar General of India.
44. Registrar General of India. 2009. Sample Registration System. Sample Registration System Bulletin 44: 1-6.
45. Singhi P, Bansal A, Geeta P, Singhi S. 2007. Predictors of long-term neurological outcome in bacterial meningitis. Indian Journal of Pediatrics 74: 369-74.
46. UNICEF. 2008. UNICEF Supply and Logistics. 2008 vaccine projections. Online at: http://www.unicef.org/supply/files/Copy-of-2008-Vaccine-Projection- March-2008.pdf, accessed 1 March 2012.
47. UNICEF. 2009. Product menu for vaccines supplied by UNICEF for the GAVI Alliance. Online at: http://www.unicef.org/supply/files/Product-Menu-24-Nov- 2009-published.pdf, accessed 7 February 2011.
48. UNICEF 2010. Product menu for vaccines supplied by UNICEF for Global Alliance for Vaccine and Immunization. Online at http://www.unicef.org/supply/ files/Product-Menu-Nov-2010-Published .pdf, accessed 28 September 2011.
49. UNICEF. 2010. Coverage Evaluation Survey 2009. National Fact Sheet. United Nations Children Fund, India Country Office. Online at: http://www.unicef.org/india/National-Fact-Sheet-CES-2009.pdf, accessed 25 January 2011.
50. Watt JP, Wolfson LJ, O'Brien KL et al. 2009. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. The Lancet 374: 903-11.
51. WHO. 2001. Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children. World Health Organization Pneumonia Vaccine Trial Investigators' Group. Online at: http://whqlibdoc.who.int/hq/2001/WHO- V&B-01.35.pdf, accessed 1 March 2012.
52. WHO 2004. The Global Burden of Disease: 2004 Update. Geneva:World Health Organization.
53. WHO. 2005. Vaccine Introduction Guidelines: Adding a vaccine to a national immunization programme. Online at: http://www.who.int/vaccines- documents/DocsPDF05/777-screen.pdf, accessed 16 March 2010.
54. WHO. 2006a. Mortality country fact sheet. 2006 Geneva: World Health Organization. Online at: http://www.who.int/whosis/mort/profiles/mort-searo-ind- india.pdf, accessed 21 July 10.
55. WHO. 2006b. Review of the disease burden of Haemophilus influenzae type b (hib), and the use and cost-effectiveness of hib vaccination in the Western pacific region. Online at http://www.wpro.who.int/NR/rdonlyres/73D4EAFD-DD20- 4CEC-BA66-8752FDB4D996/0/Hib ReviewWPR.pdf, accessed 2 October 2008.
56. WHO. 2006c. WHO Position Paper on Haemophilus influenzae type b conjugate vaccines. Weekly Epidemiological Record 47: 442-45.
57. World Bank. 2010. World Bank list of economies. Online at: http://web .worldbank.org/WBSITE/EXTERNAL/DATASTATISTICS/0, accessed 16 March 2010.
58. Wenger JD. 1998. Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada. Pediatric Infectious Disease Journal 17(9 Suppl.):5132-6.